Skip to main content
. 2023 Dec 23;15(1):27. doi: 10.3390/genes15010027

Figure 4.

Figure 4

Percentage of variants shared, lost or gained between matched pre- and post-chemotherapy tumors from 10 patients (A). Average percentage of variants gained or lost in pre-post chemotherapy matched samples (B). NR (non-responder), R (responder). * p < 0.05 (unpaired t-test).